A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor

Science

Volumn 281, Issue 5374, 1998, Pages 257-259

  Tian, Shin Shay ^a   Lamb, Peter ^a   King, Andrew G ^b   Miller, Stephen G ^a   Kessler, Linda ^a   Luengo, Juan I ^b   Averill, Laurie ^b   Johnson, Randall K ^b   Gleason, John G ^b   Pelus, Louis M ^b   Dillon, Susan B ^b   Rosen, Jonathan ^a  

^a LIGAND PHARMACEUTICALS INC   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; HORMONE RECEPTOR INTERACTION; HORMONE STRUCTURE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS;

ANIMALS; BENZIMIDAZOLES; CELL LINE; COLONY-FORMING UNITS ASSAY; DIMERIZATION; DNA-BINDING PROTEINS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; GUANIDINES; HUMANS; JANUS KINASE 1; JANUS KINASE 2; LEUKOCYTE COUNT; LEUKOPOIESIS; MICE; MICE, INBRED C57BL; MILK PROTEINS; NEUTROPHILS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION; TUMOR CELLS, CULTURED;

MURINAE;

EID: 0032504007     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.281.5374.257     Document Type: Article

References (28)

1. C.-H. Heldin, Cell 80, 213 (1995).
2. J. A. Wells and A. M. d. Vos, Annu. Rev. Biochem. 65, 609 (1996).
3. M. Fourcin et al., J. Biol. Chem. 271, 11756 (1996); T. Takahashi et al., ibid., p. 17555.
4. M. Fourcin et al., J. Biol. Chem. 271, 11756 (1996); T. Takahashi et al., ibid., p. 17555.
5. N. C. Wrighton et al., Science 273, 458 (1996); S. E. Cwirla et al., ibid. 276, 1696 (1997).
6. N. C. Wrighton et al., Science 273, 458 (1996); S. E. Cwirla et al., ibid. 276, 1696 (1997).
7. G. D. Demetri and J. D. Griffin, Blood 78, 2791 (1991); P. Anderlini, D. Przepiorka, R. Champlin, M. Korbling, ibid. 88, 2819 (1996).
8. G. D. Demetri and J. D. Griffin, Blood 78, 2791 (1991); P. Anderlini, D. Przepiorka, R. Champlin, M. Korbling, ibid. 88, 2819 (1996).
9. K. Welte, J. Gabrilove, M. H. Bronchud, E. Platzer, G. Morstyn, ibid. 88, 1907 (1996).
10. J. N. Ihle, B. A. Witthuhn, F. W. Quelle, K. Yamamoto, O. Silvennoinen, Annu. Rev. Immunol. 13, 369 (1995).
11. S.-S. Tian, P. Lamb, H. M. Seidel, R. B. Stein, J. Rosen, Blood 84, 1760 (1994); S. E. Nicholson, U. Novak, S. F. Ziegler, J. E. Layton, ibid. 86, 3698 (1995); K. Shimoda et al., ibid. 90, 597 (1997).
12. S.-S. Tian, P. Lamb, H. M. Seidel, R. B. Stein, J. Rosen, Blood 84, 1760 (1994); S. E. Nicholson, U. Novak, S. F. Ziegler, J. E. Layton, ibid. 86, 3698 (1995); K. Shimoda et al., ibid. 90, 597 (1997).
13. S.-S. Tian, P. Lamb, H. M. Seidel, R. B. Stein, J. Rosen, Blood 84, 1760 (1994); S. E. Nicholson, U. Novak, S. F. Ziegler, J. E. Layton, ibid. 86, 3698 (1995); K. Shimoda et al., ibid. 90, 597 (1997).
14. C. Schindler and J. E. Darnell, Annu. Rev. Biochem. 64, 621 (1995).
15. S.-S. Tian et al., Blood 88, 4435 (1996).
16. IL-3 was withdrawn from NFS60 cells. A cytokine-independent variant of NFS60 grew out, which was used for transfection experiments. The G-CSF signaling characteristics of this line are similar to the parental NFS60S. This line was transfected by electroporation with the plasmid 4×TTCC1Ctkluc, which contains four copies of the STAT-binding element 5′-GATCTGCTTCCCGGAACGT-3′ cloned into the plasmid tk-luc (21), and the plasmid pSV2neo, which confers neomycin resistance. Single drug-resistant clones were isolated by limiting dilution and screened for increased luciferase expression after a 2.5-hour exposure to 10 ng/ml G-CSF.
17. The plasmid RSVluc, containing the Rous sarcoma virus long terminal repeat linked to luciferase, was transfected into the cytokine-independent NFS60 line with the plasmid pSV2neo conferring neomycin resistance. Single drug-resistant clones were isolated by limiting dilution and were screened for luciferase production before and after a 2.5-hour treatment with 10 ng/ml G-CSF. A clone showing no response to G-CSF was expanded.
18. S.-S. Tian et al. data not shown.
19. Z. Zhong, Z. Wen, J. E. Darnell, Science 264, 95 (1994).
20. N. Komatsu et al., Blood 82, 456 (1993).
21. R. Fukunaga, E. Ishizaka-Ikeda, Y. Seto, S. Nagata, Cell 61, 341 (1990).
22. D. P. Aden, A. Fogel, S. Plotkin, I. Damjanov, B. B. Knowles, Nature 282, 615 (1979).
23. R. Fukunaga, E. Ishizaka-Ikeda, C.-X. Pan, Y. Seto, S. Nagata, EMBO J. 10, 2855 (1991).
24. D. Metcalf and N. A. Nicola, J. Cell. Physiol. 116, 198 (1983).
25. T. Horan et al., Biochemistry 35, 4886 (1996); O. Hiraoka, H. Anaguchi, Y. Ota, FEBS Lett. 356, 255 (1994).
26. T. Horan et al., Biochemistry 35, 4886 (1996); O. Hiraoka, H. Anaguchi, Y. Ota, FEBS Lett. 356, 255 (1994).
27. H. M. Seidel et al., Proc. Natl. Acad. Sci. U.S.A. 92, 3041 (1995).
28. We thank C. Sincich and P. Sanders for technical assistance and R. Chedester for help with the manuscript.